fbpx
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two investigational therapies in its pharmaceutical pipeline after reporting new clinical results, including a dual‑action dry eye drop entering Phase 3 and a topical TRPV1 antagonist showing early efficacy in reducing ocular pain.

Dual‑Action Dry Eye Drop to Enter Phase 3

The company confirmed that its lifitegrast + PFHO combination eye drop will progress to Phase 3 trials. The therapy is designed to target both inflammatory and evaporative components of dry eye disease — two mechanisms typically treated separately.

A Phase 2 study involving 443 patients did not meet its Day 29 primary endpoint but showed a statistically significant improvement at Day 15, a timepoint accepted by the FDA for corneal staining outcomes. At Day 15, 41.6% of patients using the combination achieved a ≥3‑unit improvement in corneal staining, compared with 18.8% on lifitegrast alone.

Safety findings were consistent with the known profiles of XIIDRA® and MIEBO®, with no new signals reported. Phase 3 trials will use Day 15 as the primary endpoint.

TRPV1 Antagonist Shows Strong Early Pain Reduction

Bausch + Lomb also reported positive Phase 1b results for BL1332, a first‑in‑class topical TRPV1 antagonist being developed for ocular surface pain. In a capsaicin‑challenge model, BL1332 produced a statistically significant reduction in pain intensity versus vehicle and shortened pain duration from 37.8 seconds to 1.6 seconds.

Exploratory findings showed complete pain resolution in 68.2% of treated eyes, compared with 0% in the vehicle group. No severe pain was reported among BL1332‑treated participants.

BL1332 is currently being evaluated in a Phase 2 study in patients experiencing pain after photorefractive keratectomy, with topline results expected in the coming months.

Next Steps

Both programs are expected to continue through late‑stage development. Bausch + Lomb has indicated that future studies will explore broader applications for BL1332 across multiple ocular pain conditions.

Source: Bausch + Lomb

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Featured Posts

optikConEd Nov 2026

OptikConEd Launches New Site with Regional Course Listings and Value Pricing

OptikConEd has launched a redesigned continuing education website with region-specific course listings, prepaid course packages and an updated account dashboard. Use promo code Optik20 for 20% off a purchase through December 11, 2026.

Learn More
Optometry practice succession planning

A Woman’s Journey Through Five Decades of Optometry

Discover Dr. Diana M. Monea’s 48-year journey in optometry. Learn essential lessons on women in leadership, independent practice building, and succession planning.

Read more
Voila Optik November-December 2026 Marchon Canada Goose GC26601SE

Canada Goose: Minimalism with a Technical Edge

The Canada Goose GC26601SE updates the brand’s Barrel Hinge Evolution concept with a sleeker profile, sustainable Acetate Renew and subtle wordmark detailing.

Read more
Newton (Neurolens) logo

Newton’s Neurolens® N3 Receives CE Marking Under EU MDR

Newton’s Neurolens N3 has received CE marking under EU MDR, enabling expansion of its eye alignment measurement technology into European markets starting in 2027.

Read more
Moisture Vue logo

MoistureVue Introduces Moisture Chamber Technology for Everyday Dry Eye Relief

MoistureVue has introduced MoistureVue Clear, a reusable eye guard that brings moisture chamber technology to everyday eyewear for dry eye symptom relief.

Read more
optikConEd Nov 2026

OptikConEd Launches New Site with Regional Course Listings and Value Pricing

OptikConEd has launched a redesigned continuing education website with region-specific course listings, prepaid course packages and an updated account dashboard. Use promo code Optik20 for 20% off a purchase through December 11, 2026.

Learn More
Optometry practice succession planning

A Woman’s Journey Through Five Decades of Optometry

Discover Dr. Diana M. Monea’s 48-year journey in optometry. Learn essential lessons on women in leadership, independent practice building, and succession planning.

Read More
Voila Optik November-December 2026 Marchon Canada Goose GC26601SE

Canada Goose: Minimalism with a Technical Edge

The Canada Goose GC26601SE updates the brand’s Barrel Hinge Evolution concept with a sleeker profile, sustainable Acetate Renew and subtle wordmark detailing.

Read More
Newton (Neurolens) logo

Newton’s Neurolens® N3 Receives CE Marking Under EU MDR

Newton’s Neurolens N3 has received CE marking under EU MDR, enabling expansion of its eye alignment measurement technology into European markets starting in 2027.

Read More
Moisture Vue logo

MoistureVue Introduces Moisture Chamber Technology for Everyday Dry Eye Relief

MoistureVue has introduced MoistureVue Clear, a reusable eye guard that brings moisture chamber technology to everyday eyewear for dry eye symptom relief.

Read More
optikConEd Nov 2026

OptikConEd Launches New Site with Regional Course Listings and Value Pricing

OptikConEd has launched a redesigned continuing education website with region-specific course listings, prepaid course packages and an updated account dashboard. Use promo code Optik20 for 20% off a purchase through December 11, 2026.

Learn More
Optometry practice succession planning

A Woman’s Journey Through Five Decades of Optometry

Discover Dr. Diana M. Monea’s 48-year journey in optometry. Learn essential lessons on women in leadership, independent practice building, and succession planning.

Read more
Voila Optik November-December 2026 Marchon Canada Goose GC26601SE

Canada Goose: Minimalism with a Technical Edge

The Canada Goose GC26601SE updates the brand’s Barrel Hinge Evolution concept with a sleeker profile, sustainable Acetate Renew and subtle wordmark detailing.

Read more
Newton (Neurolens) logo

Newton’s Neurolens® N3 Receives CE Marking Under EU MDR

Newton’s Neurolens N3 has received CE marking under EU MDR, enabling expansion of its eye alignment measurement technology into European markets starting in 2027.

Read more
Moisture Vue logo

MoistureVue Introduces Moisture Chamber Technology for Everyday Dry Eye Relief

MoistureVue has introduced MoistureVue Clear, a reusable eye guard that brings moisture chamber technology to everyday eyewear for dry eye symptom relief.

Read more
optikConEd Nov 2026

OptikConEd Launches New Site with Regional Course Listings and Value Pricing

OptikConEd has launched a redesigned continuing education website with region-specific course listings, prepaid course packages and an updated account dashboard. Use promo code Optik20 for 20% off a purchase through December 11, 2026.

Learn More
Optometry practice succession planning

A Woman’s Journey Through Five Decades of Optometry

Discover Dr. Diana M. Monea’s 48-year journey in optometry. Learn essential lessons on women in leadership, independent practice building, and succession planning.

Read more
Voila Optik November-December 2026 Marchon Canada Goose GC26601SE

Canada Goose: Minimalism with a Technical Edge

The Canada Goose GC26601SE updates the brand’s Barrel Hinge Evolution concept with a sleeker profile, sustainable Acetate Renew and subtle wordmark detailing.

Read more
Newton (Neurolens) logo

Newton’s Neurolens® N3 Receives CE Marking Under EU MDR

Newton’s Neurolens N3 has received CE marking under EU MDR, enabling expansion of its eye alignment measurement technology into European markets starting in 2027.

Read more
Moisture Vue logo

MoistureVue Introduces Moisture Chamber Technology for Everyday Dry Eye Relief

MoistureVue has introduced MoistureVue Clear, a reusable eye guard that brings moisture chamber technology to everyday eyewear for dry eye symptom relief.

Read more